These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 14570665)

  • 1. Mu-opioid receptor mRNA regulation during morphine tolerance in the rat peripheral nervous system.
    Meuser T; Giesecke T; Gabriel A; Horsch M; Sabatowski R; Hescheler J; Grond S; Palmer PP
    Anesth Analg; 2003 Nov; 97(5):1458-1463. PubMed ID: 14570665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
    Wang HY; Friedman E; Olmstead MC; Burns LH
    Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic naloxone-induced supersensitivity affects neither tolerance to nor physical dependence on morphine at hypothalamus-pituitary-adrenocortical axis.
    Alcaraz C; Vargas ML; Milanés MV
    Neuropeptides; 1996 Feb; 30(1):29-36. PubMed ID: 8868296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-Dose Cannabinoid Type 2 Receptor Agonist Attenuates Tolerance to Repeated Morphine Administration via Regulating μ-Opioid Receptor Expression in Walker 256 Tumor-Bearing Rats.
    Zhang M; Wang K; Ma M; Tian S; Wei N; Wang G
    Anesth Analg; 2016 Apr; 122(4):1031-7. PubMed ID: 26720619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of morphine tolerance and dependence by diazepam and its relation to mu-opioid receptors in the rat brain and spinal cord.
    Tejwani GA; Sheu MJ; Sribanditmongkol P; Satyapriya A
    Brain Res; 1998 Jun; 797(2):305-12. PubMed ID: 9666154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the antihyperalgesic action of a novel peripheral mu-opioid receptor agonist--loperamide.
    Nozaki-Taguchi N; Yaksh TL
    Anesthesiology; 1999 Jan; 90(1):225-34. PubMed ID: 9915332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of Mas oncogene-related gene (Mrg) C receptors enhances morphine-induced analgesia through modulation of coupling of μ-opioid receptor to Gi-protein in rat spinal dorsal horn.
    Wang D; Chen T; Zhou X; Couture R; Hong Y
    Neuroscience; 2013 Dec; 253():455-64. PubMed ID: 24042038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prohormone convertase 2 (PC2) null mice have increased mu opioid receptor levels accompanied by altered morphine-induced antinociception, tolerance and dependence.
    Lutfy K; Parikh D; Lee DL; Liu Y; Ferrini MG; Hamid A; Friedman TC
    Neuroscience; 2016 Aug; 329():318-25. PubMed ID: 27208618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
    Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
    J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of morphine tolerance by spinal melanocortin receptor blockade.
    Starowicz K; Obara I; Przewłocki R; Przewlocka B
    Pain; 2005 Oct; 117(3):401-411. PubMed ID: 16153779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of transient naloxone antagonism on tolerance development in rats receiving continuous spinal morphine infusion.
    Ibuki T; Dunbar SA; Yaksh TL
    Pain; 1997 Apr; 70(2-3):125-32. PubMed ID: 9150285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultra-low dose naloxone upregulates interleukin-10 expression and suppresses neuroinflammation in morphine-tolerant rat spinal cords.
    Lin SL; Tsai RY; Tai YH; Cherng CH; Wu CT; Yeh CC; Wong CS
    Behav Brain Res; 2010 Feb; 207(1):30-6. PubMed ID: 19799935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in the morphine-induced inhibition of small and large intestinal transit: Involvement of central and peripheral μ-opioid receptors in mice.
    Matsumoto K; Umemoto H; Mori T; Akatsu R; Saito S; Tashima K; Shibasaki M; Kato S; Suzuki T; Horie S
    Eur J Pharmacol; 2016 Jan; 771():220-8. PubMed ID: 26712376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal nitric oxide modulates morphine antinociceptive tolerance by enhancing constitutive activity of the mu-opioid receptor.
    Heinzen EL; Booth RG; Pollack GM
    Biochem Pharmacol; 2005 Feb; 69(4):679-88. PubMed ID: 15670586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultra-low dose naloxone restores the antinociceptive effect of morphine in pertussis toxin-treated rats by reversing the coupling of mu-opioid receptors from Gs-protein to coupling to Gi-protein.
    Tsai RY; Tai YH; Tzeng JI; Cherng CH; Yeh CC; Wong CS
    Neuroscience; 2009 Dec; 164(2):435-43. PubMed ID: 19682558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid agonist efficacy predicts the magnitude of tolerance and the regulation of mu-opioid receptors and dynamin-2.
    Pawar M; Kumar P; Sunkaraneni S; Sirohi S; Walker EA; Yoburn BC
    Eur J Pharmacol; 2007 Jun; 563(1-3):92-101. PubMed ID: 17349996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of testosterone in mu-opioid receptor expression in the trigeminal ganglia of opioid-tolerant rats.
    Bai X; Wang C; Zhang X; Feng Y; Zhang X
    Neurosci Lett; 2020 Apr; 723():134868. PubMed ID: 32109552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
    J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YFa, a chimeric opioid peptide, induces kappa-specific antinociception with no tolerance development during 6 days of chronic treatment.
    Vats ID; Dolt KS; Kumar K; Karar J; Nath M; Mohan A; Pasha MA; Pasha S
    J Neurosci Res; 2008 May; 86(7):1599-607. PubMed ID: 18183621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of TRPV1-expressing sensory neurons reduces spinal mu opioid receptors but paradoxically potentiates opioid analgesia.
    Chen SR; Pan HL
    J Neurophysiol; 2006 May; 95(5):3086-96. PubMed ID: 16467418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.